Skip to main content
Marketing

AHPRA Treatment Naming: What Your Clinic Website Can and Cannot Say

Australian cosmetic clinics cannot name Schedule 4 prescription substances like Botox, Dysport, or Juvederm in advertising, including website treatment pages. This guide covers the compliant naming conventions for injectables, fillers, and energy-based devices after AHPRA's September 2025 amendments.

Vikas Thakur Vikas Thakur Updated Jun 21, 2026 5 min read
Australian cosmetic clinics cannot name Schedule 4 prescription substances like Botox, Dysport, or Juvederm in advertising, including website treatment pages. This guide covers the compliant naming conventions for injectables, fillers, and energy-based devices after AHPRA's September 2025 amendments.

Key Takeaways

  • Schedule 4 substances cannot be named in any advertising context, including website treatment pages
  • This applies to brand names (Botox, Dysport, Juvederm) and generic names when used promotionally (botulinum toxin type A in a booking context)
  • “Anti-wrinkle injections”, “dermal filler”, “lip filler” are all compliant treatment category names
  • The ban applies to URLs, page titles, meta descriptions, image alt text, and social media hashtags
  • Practitioners can discuss substance names in a clinical/educational context within a consultation, but not in advertising
  • Google and Meta also restrict Schedule 4 substance names in paid advertising independently of AHPRA
  • A website treatment page naming Botox 47 times is still a breach, even if every other element is compliant
  • Post-September 2025, AHPRA’s enforcement team actively searches for substance brand names in website content

It’s a Tuesday morning. A cosmetic clinic’s marketing manager rewrites all their ad copy to be AHPRA-compliant. New headlines, no testimonials, no before/after, no outcome language.

The website still says “Botox” 47 times.

AHPRA doesn’t care that the ads are clean if the page they lead to is not. Website content that functions as advertising is advertising. That is the legal test, not whether the content lives on a “website” or an “ad”.

Here’s exactly what needs to change.


Not all website content is advertising under the National Law. AHPRA applies a functional test: does this content influence someone to seek out or use a regulated health service?

If yes, it is advertising, and the restrictions apply.

Content TypeIs It Advertising?AHPRA’s Position
Treatment page (“Book Botox in Perth”)YesAdvertising: names Schedule 4 substance promotionally
Blog post on how anti-wrinkle injections workDependsEducational if no booking CTA; advertising if it promotes bookings
FAQ page on what to expect during a dermal filler consultationUsually yesContains a service promotion element
Practitioner credentials pageUsually noNot promoting a specific service
Consent form on a patient portalNoNot publicly accessible advertising
Google Business Profile postsYesAdvertising
Image alt text on treatment photosYesPart of the broader advertising context

If a page has a booking button or a “contact us” CTA, treat the entire page as advertising. That is the safer position.


Schedule 4 Substance Names: Full Banned List

The following substance names cannot appear in advertising context. This is not exhaustive but covers the most commonly used cosmetic injectables in Australia.

Banned brand names

Product TypeBanned Brand Names
Anti-wrinkle / botulinum toxinBotox, Dysport, Xeomin, Azzalure, Bocouture
Dermal filler (hyaluronic acid)Juvederm, Restylane, Belotero, Stylage, Teosyal
Dermal filler (other)Sculptra, Radiesse, Ellanse
Fat-dissolvingBelkyra (deoxycholic acid brand)
Skin boosterProfhilo, Jalupro

What about generic names?

Generic names (botulinum toxin, hyaluronic acid) are not automatically banned. The test is whether they are used in an advertising context. “This treatment uses hyaluronic acid filler” on an educational page explaining the science is likely fine. “Book hyaluronic acid filler — from $450” on a booking page is advertising and is more exposed.

The safest approach: use treatment category language throughout all client-facing content and reserve substance-specific clinical language for the consultation itself.


Compliant Naming Conventions

These are the approved treatment category names to use in place of brand or generic substance names.

TreatmentNon-Compliant (Name Brand)Compliant (Category Name)
Anti-wrinkle treatmentBotox, Dysport, XeominAnti-wrinkle injections
Lip augmentationJuvederm lip filler, Restylane KysseLip filler, lip augmentation
Cheek augmentationJuvederm VolumaCheek filler, cheek augmentation
Jawline definitionJuvederm VoluxJawline filler, jawline contouring
Skin boosterProfhilo, Jalupro injectionSkin booster injections
Fat dissolvingBelkyraDeoxycholic acid treatment, fat dissolving injections
Collagen stimulatorSculptraCollagen stimulator, biostimulator filler

Diagram showing pie chart data visualization related to Ahpra Treatment Naming Clinic Website


What Needs to Change on Your Website

A compliant treatment naming audit covers every location where substance brand names appear.

Check these locations

Page content:

  • Treatment page headings and body copy
  • FAQ pages (especially “What is Botox?”, “How does Juvederm work?“)
  • Blog posts that mention product names in an advertising context
  • Team and practitioner bio pages (if they list “Botox certified”)

Technical locations:

  • Page URL slugs (/botox-perth/ needs to become /anti-wrinkle-injections-perth/)
  • Meta titles and descriptions
  • Image file names and alt text (botox-before-after.jpg needs renaming)
  • Structured data (FAQ schema, service schema)

Off-site locations:

  • Google Business Profile service list
  • Google Business Profile posts
  • Facebook and Instagram bios, post captions, and highlights covers
  • Linktree or link-in-bio pages

Diagram showing visual representation of data and relationships related to Ahpra Treatment Naming Clinic Website

URL redirects

Changing /botox-perth/ to /anti-wrinkle-injections-perth/ removes the non-compliant URL, but the old URL may have backlinks and Google Search Console data. Set up a 301 redirect from the old URL to the new one so you do not lose traffic while the compliant version builds authority.

Changing the URL slug is not optional. A page titled “Botox Perth” still advertises a Schedule 4 substance by name, regardless of what the page body says.


The Practitioner Certificate Exception

One area that causes confusion: practitioners often list their training and certifications on their bio pages. “Certified advanced injector, Allergan Master Injector Program” is an example.

AHPRA’s position is that clinical qualifications and training certificates are not advertising if presented as factual credential information without a promotional context. A practitioner bio page that lists qualifications, experience, and professional associations is generally not advertising.

The grey area is when those credentials appear alongside a booking CTA. “Dr Sarah Jones, Allergan Master Injector — Book now” puts the credential in an advertising context and is more exposed.

Safest practice: keep practitioner bio pages separate from treatment booking pages. List credentials factually, without service promotion language on the same page.


Get a Free Website Naming Audit

RockingWeb audits cosmetic clinic websites for AHPRA treatment naming compliance. We identify every instance of non-compliant substance names, produce a prioritised remediation list, and handle the URL redirect map.

Request your free AHPRA website compliance audit

Related reading:

Vikas Thakur
About the author

Vikas Thakur

Founder of RockingWeb. 16 years building for companies like TPG, iiNet and Monadelphous, now focused on websites and marketing that comply with AHPRA's advertising guidelines and still book patients.

16 years engineering AHPRA-focused 500+ projects delivered
4.9/5 Trusted by 50+ Australian businesses
Back to Blog

Related Posts

View All Posts »
Before-and-After Photo Rules AHPRA: Full Guide
Marketing

Before-and-After Photo Rules AHPRA: Full Guide

AHPRA's before-and-after guideline for higher risk cosmetic procedures, effective 2 September 2025, does not ban the format outright. It sets six conditions, and breaching them carries a penalty of up to $120,000 per image. Here is exactly what is banned, what is conditionally allowed, and what consent a clinic needs before publishing one.

12 min read
AHPRA Cosmetic Fines: $60,000 Per Breach Explained
Marketing

AHPRA Cosmetic Fines: $60,000 Per Breach Explained

A single AHPRA advertising breach carries a maximum penalty of $60,000 for an individual practitioner and $120,000 for a body corporate, under section 133 of the Health Practitioner Regulation National Law. Here's how the penalty is calculated, and why it multiplies fast.

8 min read
AHPRA Advertising Complaints Hit 380 a Year: Data
Marketing

AHPRA Advertising Complaints Hit 380 a Year: Data

AHPRA logged 380 advertising complaints in 2022/23, alongside 65 non-compliance findings from a targeted cosmetic surgery audit and 315 calls to its new complaints hotline. Here is what the numbers mean for clinic advertising risk.

7 min read